JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266197

Human UBXN1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

UBXN1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human UBXN1 knockout HEK-293T cell line (AB266197)
  • Sanger seq

Unknown

Sanger Sequencing - Human UBXN1 knockout HEK-293T cell line (AB266197)

Homozygous : 1 bp deletion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266197-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266197-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266197 Human UBXN1 knockout HEK-293T cell line", "number":"AB266197-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266197-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266197-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266197 Human UBXN1 knockout HEK-293T cell line", "number":"AB266197-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266197-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266197 Human UBXN1 knockout HEK-293T cell line", "number":"AB266197-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266197-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266197 Human UBXN1 knockout HEK-293T cell line", "number":"AB266197-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
UBXN1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

UBXN1 also known as UBX domain-containing protein 1 has a major role in regulating protein degradation through the ubiquitin-proteasome system. This protein weighs approximately 38 kDa. UBXN1 is expressed ubiquitously with higher levels reported in tissues such as kidney liver and brain. It interacts with the p97/VCP ATPase modulating its activity in protein degradation. By binding to ubiquitin chains UBXN1 influences the fate of many substrates targeted for degradation.
Biological function summary

UBXN1 serves as a regulator in processes such as protein homeostasis and stress response. It functions as part of a large protein complex that includes elements like p97/VCP which are central to maintaining cellular protein balance. UBXN1 modulates processes involving endoplasmic reticulum-associated degradation (ERAD). It therefore plays a role in the quality control of misfolded proteins preventing their accumulation and potential toxicity in cells.

Pathways

UBXN1 is closely associated with the ubiquitin-proteasome pathway a critical system for protein turnover. It acts along with proteins such as p97/VCP and works in tandem with ubiquitin enzymes to regulate protein substrates. Additionally UBXN1 has a role in autophagy-related pathways where it assists in removing damaged proteins and organelles cooperating with signalling proteins like LC3 which are essential for autophagic vesicle formation.

UBXN1 has connections with neurodegenerative diseases and cancer. Its involvement in protein homeostasis and degradation pathways links UBXN1 to neurodegenerative conditions where mismanagement of protein quality control is a hallmark. The dysregulation of UBXN1 alongside proteins p97/VCP has been associated with inclusion body myopathy and other degenerative diseases. Moreover alterations in UBXN1 expression or function relate to cancer progression as its imbalance can lead to uncontrolled cell growth through disrupted protein degradation mechanisms.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com